Literature DB >> 620426

Structural specificity of synthetic peptide adjuvant for induction of experimental allergic encephalomyelitis.

Y Nagai, K Akiyama, S Kotani, Y Watanabe, T Shimono, T Shiba, S Kusumoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620426     DOI: 10.1016/0008-8749(78)90136-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  6 in total

1.  Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy.

Authors:  Chikako Ogawa; Yuen-Joyce Liu; Koichi S Kobayashi
Journal:  Curr Bioact Compd       Date:  2011-09

Review 2.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

3.  Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice.

Authors:  H Ohkuni; Y Norose; M Ohta; M Hayama; Y Kimura; M Tsujimoto; S Kotani; T Shiba; S Kusumoto; K Yokogawa; S Kawata
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

4.  Delayed-type hypersensitivity to myelin basic proteins in mice susceptible to allergic encephalomyelitis.

Authors:  D S Linthicum; G A Hashim
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

5.  Effects of natural or synthetic microbial adjuvants on induction of autoimmune thyroiditis.

Authors:  Y C Kong; F Audibert; A A Giraldo; N R Rose; L Chedid
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

Review 6.  Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy.

Authors:  Sanja Nabergoj; Irena Mlinarič-Raščan; Žiga Jakopin
Journal:  Med Res Rev       Date:  2018-12-13       Impact factor: 12.944

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.